Is Bemotrizinol Safe? Reef Safety, Side Effects, and How It Compares to Zinc Oxide

By Jane Yoo, MD, MPP, Board-Certified Dermatologist & Mohs Surgeon

Last updated: July 2026

Since the FDA’s June 2026 approval of bemotrizinol (BEMT, Tinosorb S, PARSOL Shield) as a new U.S. sunscreen active ingredient, I’ve been getting the same handful of safety questions from patients, understandably, since any “new” sunscreen ingredient tends to raise questions even when it’s been used safely abroad for 25 years. Here are direct, clinical answers to the ones I hear most.

Is Bemotrizinol Safe?

Yes. The FDA’s approval determination is that bemotrizinol is generally recognized as safe and effective (GRASE) for adults and children 6 months of age and older. This determination followed a formal safety review process, including additional studies requested by the FDA before the 2026 approval. Beyond the U.S. review, bemotrizinol has been used in sunscreens in Europe, Australia, and across Asia since 1999, over 25 years of real-world use and post-market safety monitoring with no significant safety signals identified.

Two specific safety points worth noting:

  • Low systemic absorption. Bemotrizinol is a large molecule with very low water solubility, which correlates with low absorption through the skin into the body. This matters to patients who’ve followed the broader conversation around chemical sunscreen filters and systemic absorption.
  • No concerning estrogenic activity signal. Laboratory data reviewed as part of the safety evaluation have been reassuring on this point, which is relevant to the endocrine-disruption questions that come up around some older chemical filters.

Is Bemotrizinol Reef Safe?

This is a more nuanced question than it might seem, because “reef safe” isn’t an FDA-regulated or standardized term, it’s a marketing designation, and different brands and advocacy groups apply it inconsistently. What we can say with more precision:

Bemotrizinol is chemically distinct from oxybenzone and octinoxate, the two filters most directly implicated in coral reef research and banned in reef-protective legislation in places like Hawaii and Key West. Bemotrizinol is not currently named in those bans. That said, the body of independent, dedicated coral-reef research specifically on bemotrizinol is smaller than the research base on oxybenzone, simply because it hasn’t been on the U.S. market and hasn’t drawn the same regulatory scrutiny here. If reef impact is a top priority for your sunscreen choice. For example, before a trip somewhere with reef-protective sunscreen regulations. Check the specific product’s full ingredient list against that location’s rules rather than relying on a “reef safe” label alone.

What Are the Side Effects of Bemotrizinol?

In the safety data reviewed for FDA approval, bemotrizinol did not raise significant side-effect concerns distinct from what’s typical of chemical sunscreen filters generally. As with any sunscreen ingredient, a small subset of people can have a contact or sensitization reaction to any given filter. This is true of essentially every UV filter, chemical or mineral. If you have a known sensitivity to sunscreen ingredients generally, patch-testing a new product is reasonable, and it’s worth mentioning to your dermatologist which specific filters you’ve reacted to in the past, since reaction patterns are usually filter-specific rather than a blanket “chemical sunscreen” sensitivity.

Bemotrizinol vs. Zinc Oxide: How Do They Compare?

These serve different roles and aren’t strictly interchangeable. The right choice depends on what you’re prioritizing:

  Bemotrizinol (chemical filter) Zinc Oxide (mineral filter)
Mechanism  Absorbs UV radiation Primarily reflects/scatters UV radiation
UVA/UVB Coverage Strong broad-spectrum, both ranges Strong broad-spectrum, both ranges
Photostability  Highly photostable Inherently stable (doesn’t degrade in light) 
Cosmetic finish No white cast, blends invisibly  Can leave white or gray cast, especially in higher concentrations
Onset time Needs ~15-20 minutes to become effective after application  Effective immediately upon application 
Systemic absorption Low, but present (chemical filters absorb into skin to work) Minimal to none, stays on skin surface
Visible light protection  None on its own (needs iron oxide tint) None untinted (needs iron oxide tint)

Neither is categorically “better.” Many of the best-performing sunscreen formulas combine both filter types to balance cosmetic elegance with the reassurance some patients want from a mineral-only product. If white cast on medium-to-deep skin tones is your primary concern, bemotrizinol-containing formulas will likely perform better cosmetically. If you specifically want to avoid chemical UV absorbers altogether, zinc oxide remains the better fit. Just be aware that untinted zinc oxide, like untinted bemotrizinol, won’t address visible-light-driven pigmentation (see the sunscreen for melasma guide above for more on that distinction).

Frequently Asked Questions

Is bemotrizinol safe for children?

The FDA’s GRASE determination for bemotrizinol covers use in children as young as 6 months of age.

Is bemotrizinol safe during pregnancy?

Bemotrizinol generally has a favorable systemic absorption and safety profile, but any sunscreen ingredient question during pregnancy is worth a specific conversation with your OB and dermatologist, since pregnancy-specific safety data is more limited across all sunscreen filters, not just bemotrizinol.

Does bemotrizinol cause acne or clog pores?

Bemotrizinol itself is not comedogenic. Whether a specific sunscreen product causes breakouts usually comes down to the overall formula, emollients, silicones, or other ingredients in the base, rather than the bemotrizinol filter itself.

Is a “reef safe” sunscreen automatically bemotrizinol-based?

No. “Reef safe” is typically used to describe products that exclude oxybenzone and octinoxate specifically; it doesn’t mean the product contains, or excludes, bemotrizinol.

author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.